GAMMA Investing’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$18.8K Sell
2,246
-342
-13% -$3.06K ﹤0.01% 2982
2026
Q2
$25.3K Buy
2,588
+433
+20% +$4.28K ﹤0.01% 2712
2026
Q1
$20.9K Buy
2,155
+1,645
+323% +$15.1K ﹤0.01% 2691
2025
Q4
$4.87K Buy
510
+124
+32% +$1.26K ﹤0.01% 3289
2025
Q3
$3.77K Buy
386
+189
+96% +$1.45K ﹤0.01% 3279
2025
Q2
$1.2K Sell
197
-288
-59% -$2.16K ﹤0.01% 3503
2025
Q1
$6K Buy
485
+358
+282% +$5.06K ﹤0.01% 3010
2024
Q4
$1.76K Buy
127
+60
+90% +$946 ﹤0.01% 3259
2024
Q3
$1.12K Sell
67
-300
-82% -$6.45K ﹤0.01% 3227
2024
Q2
$7.58K Buy
367
+309
+533% +$6.69K ﹤0.01% 2388
2024
Q1
$1.44K Buy
58
+18
+45% +$535 ﹤0.01% 2852
2023
Q4
$1.14K Buy
+40
New +$1.54K ﹤0.01% 2757

Other funds holding PRTA

GAMMA Investing's PRTA Position: Q3 2026 in Review

GAMMA Investing reduced its Prothena Corp (PRTA) stake by 13% in Q3 2026, selling an estimated $3.06K and leaving 2,246 shares worth $18.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2982.

GAMMA Investing first reported a position in PRTA in Q4 2023 and has held it in 12 quarters since. The position peaked at $25.3K in Q2 2026. 4 funds tracked by Wall St. Rank hold PRTA as of Q3 2026.

  • GAMMA Investing held 2,246 shares of Prothena Corp worth $18.8K as of Q3 2026.
  • GAMMA Investing sold 342 Prothena Corp shares in Q3 2026, an estimated $3.06K.
  • Prothena Corp made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2982 holding.
  • GAMMA Investing first reported a position in Prothena Corp in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's Prothena Corp position peaked at $25.3K in Q2 2026.
  • 4 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.